Meticulous Research® in its latest publication on Allergy Diagnostics Market states that the global allergy diagnostics market will increase at a CAGR of around 11.1% from 2019 to 2025 to reach $7.08 billion by 2025. Allergic diseases are affecting the lives of more than one billion people worldwide. More than 50 million Americans have experienced various types of allergies each year (Source: CDC). According to American College of Allergy, Asthma, and Immunology (ACAAI), allergies are the 6th leading cause of chronic illness in the U.S and annual cost of allergies exceeds $18 billion.
Analysis of Market Segments
The allergy diagnostics market is segmented by product & service (Assay Kits, Instruments, Services), by test (In Vivo Tests, and In Vitro Tests), by allergen (inhaled allergens, food allergens, drug allergens, and others), by end-user (diagnostic laboratories, hospital-based laboratories, academic research institutes and others), and by region.
On the basis of product & service, the allergy diagnostics market is segmented into Assay Kits, Instruments, and Services. Assay kits accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to widespread availability, lower cost, and significant consumption of assay kits in allergy testing.
Based on allergen type, the global allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2018, inhaled allergens accounted for the largest share of the global allergy diagnostics market. The large share of this segment is mainly due to increasing environmental pollution across the globe.
Based on end-user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and others. Diagnostic laboratories dominated the global allergy diagnostics market in 2018. The large share and high growth of this segment is attributed to increasing number of diagnostic centers, improving diagnostic lab infrastructure in developing countries, and greater preference to conduct these tests at these centers.
This research report analyzes major geographies and provides comprehensive value and volume analysis of North America (U.S., Canada), Europe (Germany, U.K., Spain, France, Italy, and RoE), Asia-Pacific (China, India, Japan, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for largest share of the global allergy diagnostics market. However, APAC is expected to register highest growth during the forecast period. The high growth of this region is mainly attributed to rise in number of hospitals and diagnostic laboratories, large patient pool, increasing awareness of allergy diseases, and growing healthcare expenditure.
Click here to: Get Free Request Sample Pages of this Report
Key Players
The report includes the competitive landscape based on an extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years. Biomérieux SA (France), Hitachi Chemical Co., Ltd. (Japan), Hob Biotech Group Suzhou Co., Ltd. (China), Hycor Biomedical, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Omega Diagnostics Group PLC (U.K.), R-Biopharm AG (Germany), Stallergenes Greer (U.K.), Siemens AG (Germany), and Thermo Fisher Scientific Inc. (U.S.) are the key players operating in this market. The players are adopting various organic and inorganic growth strategies in order to strengthen their presence and customer base.
Market Segmentation:
Allergy Diagnostics Market, By Product & Service
- Assay Kits
- Instruments
- Immunoassay Analyzers
- Luminometers
- Elisa Analyzers
- Other Instruments
- Services
Allergy Diagnostics Market, By Test
- In Vivo Tests
- In Vitro Tests
Allergy Diagnostics Market, By Allergen
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other
Allergy Diagnostics Market, By End User
- Diagnostic Laboratories
- Hospital-based Laboratories
- Academic Research Institutes
- Other
Allergy Diagnostics Market, By Region/Country
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- RoE
- Asia-Pacific
- RoW
- Latin America
- Middle East & Africa
Key questions answered in the report:
Growing penetration of allergy diagnostic tests in developing countries will propel the overall allergy diagnostics market
- How does the adoption of allergy diagnostic tests in developed regions differ from developing countries like India and China?
- How is the competition between the major global and prominent local players in developing region?
- Which are the high growth market segments in terms of product & service, test, allergen, end users, and countries?
Diagnostic laboratories accounted for the largest share of the allergy diagnostics market globally
- What factors contribute to the frequent usage of allergy diagnostics tests in diagnostic laboratories?
- Which geographic region is expected to experience the fastest growth in the usage of allergy diagnostics in diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users?
- How does the penetration of allergy diagnostics in diagnostic laboratories differ from other end users such as hospital-based laboratories, academic research institutes, and other end users?
Allergy diagnostics market favours both larger and local manufacturers that compete in multiple segments
- What are the top competitors in this market and what strategies do they employ to gain shares?
- What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
- What strategies should new companies looking to enter in this market use to compete effectively?
- What are the major drivers, restraints, and opportunities in the allergy diagnostics market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the geographical trends and high growth regions/ countries?
Recent partnerships, acquisitions, and expansions have taken place in the global allergy diagnostics market
- What companies have recently merged/acquired and how will these unions affect the competitive landscape of the allergy diagnostics market?
- What companies have created partnerships and how will these partnerships promote a competitive advantage?
- Who are the major players in the global allergy diagnostics market and what share of the market do they hold?
- What are the local emerging players in the global allergy diagnostics market and how do they compete with the global players?